ADAMDEC1 predicts prognosis and immunotherapy response in a pan-cancer study with experimental validation
Abstract Background: ADAMDEC1 (a disintegrin and metalloproteinase domain-like protein decysin-1) is linked to immune disorders and cancers, but its pan-cancer…
